Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease

被引:94
|
作者
Fan, Zhen [1 ]
Okello, Aren A. [1 ]
Brooks, David J. [1 ,2 ]
Edison, Paul [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neurol Imaging Unit, London W12 0NN, England
[2] Aarhus Univ, Dept Nucl Med, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
Alzheimer's disease; microglia; amyloid imaging; neuropathology; dementia; VIVO RADIOLIGAND BINDING; FDG-PET; PARKINSONS-DISEASE; INFLAMMATION; BRAIN; HYPOMETABOLISM; RECEPTOR; PROTEIN; CLASSIFICATION; BIOMARKER;
D O I
10.1093/brain/awv288
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyloid deposition, tangle formation, neuroinflammation and neuronal dysfunction are pathological processes involved in Alzheimer's disease. However, the relative role of these processes in driving disease progression is still unclear. The aim of this positron emission tomography study was to: (i) investigate longitudinal changes of microglial activation, amyloid and glucose metabolism; and (ii) assess the temporospatial relationship between these three processes in Alzheimer's disease. A group of eight patients with a diagnosis of Alzheimer's disease (66 +/- 4.8 years) and 14 healthy controls (65 +/- 5.5 years) underwent T-1 and T-2 magnetic resonance imaging, along with C-11-(R)-PK11195, C-11-Pittsburgh compound B and F-18-fluorodeoxyglucose positron emission tomography scans for microglial activation, amyloid deposition and glucose metabolism. All patients were followed-up with repeated magnetic resonance imaging and three positron emission tomography scans after 16 months. Parametric maps were interrogated using region of interest analysis, Statistical Parametric Mapping, and between-group correlation analysis at voxel-level using Biological Parametric Mapping. At baseline, patients with Alzheimer's disease showed significantly increased microglial activation compared to the control subjects. During follow-up, for the first time, we found that while there is a progressive reduction of glucose metabolism, there was a longitudinal increase of microglial activation in the majority of the patients with Alzheimer's disease. Voxel-wise correlation analysis revealed that microglial activation in patients with Alzheimer's disease was positively correlated with amyloid deposition and inversely correlated with regional cerebral metabolic rate at voxel level over time. Even though one of the limitations of this study is the lack of longitudinal follow-up of healthy control subjects, this study demonstrates that there is persistent neuroinflammation throughout the Alzheimer's disease process with associated synaptic dysfunction and reduced glucose metabolism. Voxel-wise correlation analysis suggests that neuroinflammation is associated with localized amyloid deposition and glucose metabolism over time, however, the level of inflammation could also occur independently of amyloid pathology, especially in the later stages of Alzheimer's disease.
引用
收藏
页码:3685 / 3698
页数:14
相关论文
共 50 条
  • [1] Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia
    Fan, Zhen
    Aman, Yahyah
    Ahmed, Imtiaz
    Chetelat, Gael
    Landeau, Brigitte
    Chaudhuri, K. Ray
    Brooks, David J.
    Edison, Paul
    ALZHEIMERS & DEMENTIA, 2015, 11 (06) : 608 - 621
  • [2] Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    Femminella, Grazia D.
    Ninan, Siddharth
    Atkinson, Rebecca
    Fan, Zhen
    Brooks, David J.
    Edison, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1275 - 1289
  • [3] Alterations in microglial activation and amyloid deposits in Alzheimer's disease
    Ouchi, Yasuomi
    Yokokura, Masamichi
    Yagi, Shunsuke
    Kikuchi, Mitsuru
    Yoshikawa, Etsuji
    Futatsubashi, Masami
    Oboshi, Yumi
    Sakamoto, Masanobu
    Ueki, Takatoshi
    NEUROSCIENCE RESEARCH, 2010, 68 : E304 - E304
  • [4] Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
    Dani, Melanie
    Wood, Melanie
    Mizoguchi, Ruth
    Fan, Zhen
    Walker, Zuzana
    Morgan, Richard
    Hinz, Rainer
    Biju, Maya
    Kuruvilla, Tarun
    Brooks, David J.
    Edison, Paul
    BRAIN, 2018, 141 : 2740 - 2754
  • [5] Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease
    Higuchi, Makoto
    NEUROBIOLOGY OF AGING, 2008, 29 : S11 - S12
  • [6] Visualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimer's Disease
    Higuchi, Makoto
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (02) : 137 - 143
  • [7] Microglial Activation in Alzheimer's Disease
    Schlachetzki, Johannes C. M.
    Huell, Michael
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (06) : 554 - 563
  • [8] Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease
    Rogers, J
    Lue, LF
    NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (5-6) : 333 - 340
  • [9] Plasma level of Amyloid β42 Is independent of neuronal function in Alzheimer's Disease
    Fereshteh Sedaghat
    Anna Gotzamani-Psarrakou
    Vassiliki Costa
    Eleni Dedousi
    Athanasios S Dimitriadis
    Stavros J Baloyannis
    Annals of General Psychiatry, 7 (Suppl 1)
  • [10] In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease
    Masamichi Yokokura
    Norio Mori
    Shunsuke Yagi
    Etsuji Yoshikawa
    Mitsuru Kikuchi
    Yujiro Yoshihara
    Tomoyasu Wakuda
    Genichi Sugihara
    Kiyokazu Takebayashi
    Shiro Suda
    Yasuhide Iwata
    Takatoshi Ueki
    Kenji J. Tsuchiya
    Katsuaki Suzuki
    Kazuhiko Nakamura
    Yasuomi Ouchi
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 343 - 351